Alpha 2.0
Login Register
» Articles » PMID: 27898620

Intra-arterial Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma

Overview
Journal Int Ophthalmol Clin
Specialty Ophthalmology
Date 2016 Nov 30
PMID 27898620
Citations 4
Authors
Matthew Zhang
Cherie Fathy
Mark P Breazzano
Matthew Hollar
Behin Barahimi
Affiliations
Soon will be listed here.
Citing Articles

Neoadjuvant Intra-arterial Cytoreductive Chemotherapy Improves Outcomes in Lacrimal Gland Adenoid Cystic Carcinoma.

Costa P, Tse D, Benedetto P Oncologist. 2024; 29(3):263-269.

PMID: 38227581 PMC: 10911902. DOI: 10.1093/oncolo/oyad346.

Current Trends in the Management of Epithelial Lacrimal Gland Tumors: A Retrospective National Cancer Database Analysis.

Ashok Kumar P, Wang D, Huang D, Paulraj S, Sivapiragasam A Cureus. 2022; 14(7):e27109.

PMID: 36000118 PMC: 9391612. DOI: 10.7759/cureus.27109.

Bevacizumab is an Efficient Therapeutic Approach with Low Side Effects in Patient-Derived Xenografts of Adenoid Cystic Carcinoma of the Lacrimal Gland.

Zhang J, Yan X, Liu R, Wu S, Liu Q, Li J Cancer Manag Res. 2022; 14:1023-1032.

PMID: 35283648 PMC: 8912937. DOI: 10.2147/CMAR.S352623.

Similar therapeutic effects of I seed radiotherapy and γ-ray radiotherapy on lacrimal gland adenoid cystic carcinoma.

Liu R, Shi J, Ge X, Yang B, Zhang H, Zhang J Int J Ophthalmol. 2021; 14(4):547-553.

PMID: 33875946 PMC: 8025165. DOI: 10.18240/ijo.2021.04.11.